Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Ronald Baumgarten Expects Upcoming Trade Policies to be Similar to Last Republican Administration

Patrick Campbell, Jonathan New Author Law360 Article on Whistleblower Programs

DOJ Antitrust Division Adds to Guidance on the Evaluation of Corporate Compliance Programs in Criminal Antitrust Investigations

BakerHostetler Alumni Newsletter – Fall 2024

Representing clients in government contracts procurements, and in litigation before the Boards of Contract Appeals, the U.S. Court of Federal Claims and the Government Accountability Office, Stephen also advises in protest practice before the Small Business Administration and in matters relating to federal procurement of commercial items and services, including those under Federal Supply Schedule (FSS) contracts.

His work encompasses a broad range of contracts and policy matters, including negotiations, compliance, claims and disputes. Issues addressed include country of origin and domestic sourcing, supplies and services indefinite delivery, indefinite quantity (IDIQ) task order contracts, fixed price and cost reimbursement contracts, government-funded research and related FAR, DFAR and other CFR provisions, subcontract negotiations and disputes and federal debarment and suspension.

Stephen counsels clients on federal procurement with respect to the Departments of Veterans Affairs (VA), Defense and Health and Human Services. He also advises on government pricing laws and regulations governing pharmaceutical manufacturer participation in the Centers for Medicare &amp; Medicaid Services Medicaid Drug Rebate, Medicare, the 340B drug pricing, TRICARE retail pharmacy and Veterans Healthcare Act programs; VA FSS contracts; DOD DAPA and ECAT; and public policy affecting these programs.

core/freeform

J.D., Catholic University of America, Columbus School of Law, 1991

B.A., University of North Carolina at Chapel Hill, 1986

<ul>
<li>The Legal 500 United States
<ul>
<li>Recommended in Government Contracts (2024)</li>
</ul>
</li>
</ul>


Washington, D.C.

Federal Contractors Must File Objections to Prevent the Release of EEO-1 Reports Under FOIA

BakerHostetler attorneys, practice areas stand out in The Legal 500 annual guide

Stephen Ruscus Co-Leads Pharmaceutical Pricing Summer Weekly Webinar Series

Stephen Ruscus Presents at BIG FOUR Pharmaceutical Pricing Boot Camp

Stephen Ruscus, Kevin Barnett, Kaitlyn Toth Contribute Chapter to Public Procurement 2024

Stephen Ruscus and Kaitlyn Toth Draw on Extensive Experience with Competition Requirements for Federal Acquisition Regulations Webinar

Ruscus and Shea discuss pharmaceutical pricing at Coalition for Government Procurement conference

Stephen Ruscus Discusses Cyber, Supply Chain Security at Training Conference

Stephen Ruscus Addresses Compliance Issues in Contracting with Key Federal Agencies

Brian Craig, Brian Johnson and Stephen Ruscus Author Chapter on Public Procurement and Government Contracts for International Guide

Stephen Ruscus and Brian Craig Speak at Government Procurement Training Conference

Data Counsel

Could Careless Coders Face False Claims Liability?

Health Law Update

Allergan Win in Medicaid Drug Rebate Statute

Stephen Ruscus Quoted in Law360 about Impactful Government Contracts Cases

Stephen Ruscus Speaks at Government Procurement Conference

Stephen Ruscus Is Distinguished Faculty at Pharmaceutical Pricing Conference

BakerHostetler Adds Government Contracts Partner in Washington

Industries

Aerospace and Defense

Government Contracts

Business

Suspension and Debarment

Independent Monitoring Services Under Administrative Agreements for Government Contractors

Ethics and Compliance Programs for Government Contractors

Affirmative Action Decision Resource Center

Life Sciences

Pharmaceutical Pricing

False Claims Act

Middle East Practice

<ul>
<li>Counseled companies of all sizes and stages across multiple industries regarding strategic planning relating to decision to accept government funding through grants, cooperative agreements, OTAs, contracts and subcontracts and related compliance considerations.</li>
<li>Counseled life sciences, defense, technology and manufacturing clients of all sizes and stages regarding government contract intellectual property issues arising under contracts, subcontracts, OTAs, grants, cooperative agreements and Cooperative Research and Development Agreements (CRADAs).</li>
<li>Counseled clients of all sizes and stages and related private equity investors regarding COVID-19-related stimulus, vaccination, Defense Production Act, PREP Act and research/production funding issues.</li>
<li>Counseled defense aerospace and life sciences clients regarding preparation and submission of requests for equitable adjustment, claims and contract termination settlements.</li>
<li>Counseled defense and life sciences clients regarding mandatory disclosure obligations and multiple voluntary disclosures to the VA, GSA and the Department of Defense.</li>
<li>Defense of Small Business Administration size protest against small construction company government contract awardee.</li>
<li>Counseled multiple small start ups and technology clients regarding obtaining SBIR and STTR funding, compliance and related government investigations.</li>
<li>Counseled multiple companies regarding Buy American Act and Trade Agreements Act procurement and compliance issues, Made in USA and import marking requirements, and emerging strategic domestic sourcing and supply chain considerations.</li>
<li>Counseled small businesses, buyers and private equity investors regarding maintenance of eligibility for small business procurement preferences.</li>
<li>Counseled sellers, buyers and underwriters on multiple government contract due diligence issues.</li>
<li>Negotiated multiple third-party-financed contracts for energy conservation measures, including infrastructure enhancements, and ESPC energy sales agreement projects for construction and operation of solar systems.</li>
<li>Counseled private equity investor regarding off-shore wind grant funding and compliance issues.</li>
<li>Conducted False Claims Act investigation pertaining to sale of medical devices under Federal Supply Schedule contract.</li>
<li>Represented multiple technology, life sciences, energy and construction clients in debarment and suspension matters.</li>
<li>Litigated U.S. Court of Federal Claims bid protest regarding implementation of Trade Agreements clause and related Federal Circuit appeal.</li>
<li>Litigated multiple GAO and Court of Federal Claims bid protests with regard to solicitation and evaluation improprieties, CICA violations, SBA non-manufacturer rule waiver and procurement consolidation issues, service contracts, IDIQ contracts and task orders, Trade Agreement Act compliance, sole source awards and Tricare formulary issues.</li>
<li>Litigated termination, cost allowability, defective pricing and statutory pricing claims before the U.S. Court of Federal Claims and boards of contract appeals.</li>
<li>More than 20 years of experience counseling pharmaceutical companies of all sizes regarding government price reporting requirements under OBRA 90, the Deficit Reduction Act of 2005, the Medicare Modernization Act, the 340B program, the Veterans Healthcare Act and emerging strategic pricing and price reporting considerations.</li>
<li>More than 20 years performing government pricing calculations, compliance reviews and system implementations for multiple pharmaceutical companies of all sizes.</li>
<li>Negotiated settlement of price reductions clause, defective pricing, overpayment and Trade Agreement clause claims against multiple U.S. pharmaceutical companies.</li>
</ul>


Stephen E. Ruscus

Stephen E. Ruscus

Experience

Recognitions and Memberships

Insights and News

Credentials

Community and Pro Bono

Areas of Focus

Industries

Services

Featured Insights